Phase II Pilot Study of Pre-Operative Celecoxib (Celebrex) in Combination With Prolonged Venous Infusion 5FU [fluorouracil] and Radiation Therapy for Patients With Stage II/III Resectable Rectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2013
At a glance
- Drugs Celecoxib (Primary) ; Fluorouracil (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2007 New trial record.